Drugs / VIAGENEX Max
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT05196191 | Jan 2022 → Dec 2023 | erectile dysfunction | VIVEX Biologics, Inc. | Terminated | No outcome recorded Stop: Business |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | VIAGENEX Max | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05196191 ↗ |
| Modality | Other / unclassified | “Collagenous membrane derived from umbilical cord” NCT05196191 ↗ |